Cargando…
Triclosan promotes epicutaneous sensitization to peanut in mice
BACKGROUND: Peanut allergy is increasing in prevalence due to unknown factors. A growing body of clinical evidence suggests sensitization to peanut occurs through the skin, supported by findings in mouse models. There is a need to identify environmental factors that promote epicutaneous sensitizatio...
Autores principales: | Tobar, Steven, Tordesillas, Leticia, Berin, M. Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820960/ https://www.ncbi.nlm.nih.gov/pubmed/27051518 http://dx.doi.org/10.1186/s13601-016-0102-2 |
Ejemplares similares
-
Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023) -
Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
por: Davis, Carla M., et al.
Publicado: (2022) -
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
por: Senti, G, et al.
Publicado: (2015) -
Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice
por: Mondoulet, Lucie, et al.
Publicado: (2012) -
The Florence Statement on Triclosan and Triclocarban
por: Halden, Rolf U., et al.
Publicado: (2017)